J. Treleaven

发表

Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)

S. Singhal, J. Mehta, D. Tait, 1999, Bone Marrow Transplantation.

Sequential development of myelodysplasia and acute myeloid leukemia but with no karyotypic evolution after autografting in a patient with Philadelphia positive acute lymphoblastic leukemia.

S. Singhal, J. Mehta, R. Powles, 1997, Leukemia & lymphoma.

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants.

S. Singhal, J. Mehta, B. Sirohi, 2000, Blood.

Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling.

S. Singhal, J. Mehta, R. Powles, 1999, Leukemia & lymphoma.

Rapid Remission Induction and Improved Disease Free Survival in Acute Myeloid Leukaemia Using Daunorubicin, ARA-C, and CCNU.

A. Barrett, J. Treleaven, D. Samson, 1990, Leukemia & lymphoma.

The importance of CD34+/CD33− cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue

D. Catovsky, I. Judson, D. Cunningham, 1998, Bone Marrow Transplantation.

Male sexual function following bone marrow transplantation.

J. Barron, R. Powles, J. Treleaven, 1991, Bone marrow transplantation.

Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?

S. Singhal, J. Mehta, B. Sirohi, 2003, Bone Marrow Transplantation.

Bone-marrow transplant from father to son and subsequent graft from son to father

R. Powles, S. Lawler, S. Milliken, 1990, The Lancet.

Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation.

D. Tait, D. Cunningham, C. Tiley, 1992, Leukemia & lymphoma.

Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an ‘operational cure’?

S. Singhal, J. Mehta, B. Sirohi, 2002, Bone Marrow Transplantation.

Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia

S. Singhal, J. Mehta, B. Sirohi, 2002, Bone Marrow Transplantation.

Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells.

S. Singhal, J. Mehta, R. Powles, 1995, Bone marrow transplantation.

Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation

S. Singhal, J. Mehta, B. Sirohi, 2000, Bone Marrow Transplantation.

Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

S. Singhal, J. Mehta, J. Treleaven, 1996, Bone marrow transplantation.

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma

J. Mehta, T. Powles, S. Ashley, 2000, British Journal of Cancer.

Melphalan/TBI is not more carcinogenic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years

S. Singhal, J. Mehta, D. Tait, 2000, Bone Marrow Transplantation.

LEUKAEMIC RELAPSE FOLLOWING CAMPATH 1 TREATED BONE MARROW TRANSPLANTATION FOR LEUKAEMIA

R. Powles, J. Treleaven, J. Millar, 1986, The Lancet.

Idarubicin, high-dose cytarabine and etoposide for remission induction in therapy-related acute myeloid leukemia.

J. Mehta, R. Powles, N. Philpott, 1994, Leukemia & lymphoma.

Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies

S. Singhal, J. Mehta, R. Powles, 1997, Bone Marrow Transplantation.

Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission

S. Singhal, J. Mehta, B. Sirohi, 2003, Bone Marrow Transplantation.

The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy.

S. Singhal, J. Mehta, T. Min, 1999, Leukemia & lymphoma.

Impact of previous high-dose therapy on outcome after allografting for multiple myeloma

S. Singhal, J. Mehta, D. Tait, 1999, Bone Marrow Transplantation.

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

S. Singhal, J. Mehta, D. Tait, 2000, Bone Marrow Transplantation.

Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.

S. Singhal, J. Mehta, R. Powles, 1995, Bone marrow transplantation.

xerostomia associated with chronic graft-versus-host disease (letter) Oral pilocarpine hydrochloride for the treatment of refractory

S. Singhal, J. Mehta, R. Powles, 2011 .

Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies.

S. Singhal, J. Mehta, R. Powles, 1997, Leukemia & lymphoma.

Oral pilocarpine hydrochloride for the treatment of refractory xerostomia associated with chronic graft-versus-host disease.

S. Singhal, J. Mehta, R. Powles, 1995, Blood.

Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse.

S. Singhal, J. Mehta, R. Powles, 1999, Leukemia & lymphoma.

Kinetics of paraprotein clearance after autografting for multiple myeloma.

S. Singhal, J. Mehta, D. Cunningham, 1995, Bone marrow transplantation.

Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors.

S. Singhal, J. Mehta, D. Tait, 1995, Bone marrow transplantation.

High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission

S. Singhal, J. Mehta, B. Sirohi, 2004, Bone Marrow Transplantation.

Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia: long-term follow-up.

S. Singhal, J. Mehta, G. Hale, 1996, Leukemia & lymphoma.

Renal dysfunction following autologous bone marrow transplantation in adult patients with acute leukemia.

S. Singhal, J. Mehta, D. Tait, 1996, Acta oncologica.

Secondary leukaemia characterised by monosomy 7 occurring post-autologous stem cell transplantation for AML

J. Swansbury, T. Min, R. Powles, 1998, Bone Marrow Transplantation.

High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study.

M. Gore, D. Talbot, R. Powles, 1990, British Journal of Cancer.

Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia

Ml Smith, A. Wotherspoon, R. Gregory, 1999, Bone Marrow Transplantation.

Metastatic extramedullary plasmacytoma of the lung.

H. Pandha, J. Treleaven, R. Powles, 1999, Leukemia & lymphoma.

Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftment

S. Singhal, J. Mehta, C. Pinkerton, 1997, Leukemia.

Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts

S. Singhal, J. Mehta, G. Middleton, 1997, Bone Marrow Transplantation.

Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma – a phase I/II feasibility and tolerance study of 17 patients

S. Singhal, J. Mehta, N. Raje, 2000, Bone Marrow Transplantation.

Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission – long-term follow-up

D. Tait, R. Powles, C. Pinkerton, 2000, Bone Marrow Transplantation.

Tumour lysis following hydrocortisone prior to a blood product transfusion in T-cell acute lymphoblastic leukaemia.

D. Grimwade, C. Tiley, R. Powles, 1992, Leukemia & lymphoma.

Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation

S. Singhal, J. Mehta, R. Powles, 1999, Bone Marrow Transplantation.

Red cell fragmentation (schistocytosis) after bone marrow transplantation

S. Singhal, J. Mehta, J. Treleaven, 1998, Bone Marrow Transplantation.

Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease

S. Singhal, J. Mehta, B. Sirohi, 2003, Bone Marrow Transplantation.

Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.

S. Singhal, J. Mehta, D. Tait, 1996, Bone marrow transplantation.

Does donor–recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?

S. Singhal, J. Mehta, D. Tait, 2002, Bone Marrow Transplantation.

Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation.

S. Singhal, J. Mehta, R. Powles, 1998, Blood.

Thrombocytopenia after bone marrow transplantation for leukaemia: changes in megakaryocyte growth and growth‐promoting activity

Y. Z. Jiang, D. Macdonald, R. Powles, 1990, British journal of haematology.

Long-term safety of GM-CSF (molgramostim) administration after allogeneic bone marrow transplantation for hematologic malignancies: five-year follow-up of a double-blind randomized placebo-controlled study.

S. Singhal, J. Mehta, R. Powles, 1997, Leukemia & lymphoma.

Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.

S. Singhal, J. Mehta, R. Powles, 1996, Bone marrow transplantation.

Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women.

S. Singhal, J. Mehta, J. Treleaven, 1996, Bone marrow transplantation.

Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation.

S. Singhal, J. Mehta, D. Catovsky, 1997, Leukemia & lymphoma.

Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy

S. Singhal, J. Mehta, J. Treleaven, 1997, Bone Marrow Transplantation.

T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure.

S. Singhal, J. Mehta, D. Catovsky, 1996, Bone marrow transplantation.

Foscarnet therapy for cytomegalovirus infection after allogeneic bone marrow transplantation.

S. Singhal, J. Mehta, J. Chang, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.

S. Singhal, J. Mehta, D. Catovsky, 1996, Bone marrow transplantation.

Listeriosis in bone marrow transplant recipients: incidence, clinical features, and treatment.

J. Mehta, J. Chang, N. Paton, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation.

S. Singhal, J. Mehta, R. Powles, 1995, Bone marrow transplantation.

Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia.

S. Singhal, J. Mehta, D. Catovsky, 1994, Bone marrow transplantation.

Comparison of Cobe Spectra and Haemonetics MCS-3P cell separators for peripheral blood stem cell harvesting.

S. Singhal, J. Mehta, R. Morilla, 1995, Bone marrow transplantation.

Outcome of autologous rescue after failed engraftment of allogeneic marrow.

S. Singhal, J. Mehta, R. Powles, 1996, Bone marrow transplantation.

Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia.

D. Talbot, R. Powles, J. Sloane, 1990, Bone marrow transplantation.

Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: an important modifiable factor influencing outcome.

S. Singhal, J. Mehta, R. Powles, 1997, Blood.

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

S. Singhal, J. Mehta, H. Pandha, 2000, Bone Marrow Transplantation.

Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia.

S. Singhal, J. Mehta, R. Powles, 1996, Bone marrow transplantation.

Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients

S. Singhal, J. Mehta, J. Treleaven, 1997, Bone Marrow Transplantation.

Leukocyte recovery and early treatment-related mortality after bone marrow transplantation.

S. Singhal, J. Mehta, R. Powles, 1997, Blood.

Paradoxical emboli after central venous catheter removal.

R. Powles, J. Treleaven, T. Price, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone marrow transplantation for primary refractory acute leukaemia.

J. Mehta, D. Tait, D. Catovsky, 1994, Bone marrow transplantation.

The implication of compromised renal function at presentation in myeloma

S. Singhal, J. Mehta, N. Raje, 2001, Medical oncology.

Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial

C. Tiley, T. Mcelwain, R. Powles, 1990, The Lancet.

Reassessing autotransplantation for acute myeloid leukaemia in first remission – a matched pair analysis of autologous marrow vs peripheral blood stem cells

S. Singhal, J. Mehta, M. Labopin, 2004, Bone Marrow Transplantation.

PLATINUM AGENTS AND SECONDARY MYELOID LEUKAEMIA: TWO CASES TREATED ONLY WITH PLATINUM‐BASED DRUGS

M. Gore, D. Catovsky, T. Min, 1996, British journal of haematology.

Bone marrow transplantation—The Marsden experience

M. Gore, R. Powles, J. Treleaven, 1987, Hematological oncology.

Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation.

S. Singhal, J. Mehta, D. Tait, 1995, Bone marrow transplantation.

LEUKAEMIC RELAPSE AFTER CAMPATH 1 TREATED BONE MARROW TRANSPLANTATION FOR LEUKAEMIA

R. Powles, J. Millar, S. Milan, 1986, The Lancet.

Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia.

S. Singhal, J. Mehta, B. Czepulkowski, 1996, Bone marrow transplantation.

Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma.

S. Singhal, J. Mehta, N. Raje, 1997, British Journal of Cancer.

Glomerular filtration rate prior to high-dose melphalan 200 mg/m2as a surrogate marker of outcome in patients with myeloma

S. Singhal, J. Mehta, B. Sirohi, 2001, British Journal of Cancer.

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

S. Singhal, J. Mehta, B. Sirohi, 2002, Bone Marrow Transplantation.

Guillain-Barré syndrome after bone marrow transplantation.

J. Mehta, R. Powles, A. Perry, 1994, Bone marrow transplantation.

Allogeneic bone marrow transplantation for primary myelofibrosis.

S. Singhal, J. Mehta, C. Pollard, 1995, Bone marrow transplantation.

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

S. Singhal, J. Mehta, M. Gore, 1997, Bone Marrow Transplantation.

No increase in relapse in patients with myeloid leukaemias receiving rhGM-CSF after allogeneic bone marrow transplantation.

C. Tiley, R. Powles, J. Catalano, 1992, Bone marrow transplantation.

Human recombinant GM-CSF in allogeneic bone marrow transplantation for leukaemia: double-blind placebo controlled trial.

C. Tiley, R. Powles, E. Gordon-Smith, 1991, Bone marrow transplantation.

High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results.

S. Singhal, J. Mehta, T. Min, 1996, Leukemia & lymphoma.

Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescue.

S. Singhal, J. Mehta, D. Cunningham, 1995, Stem cells.

Removal of tumour cells from bone marrow: An evaluation of the available techniques

J. Kemshead, J. Treleaven, J. Treleaven, 1985, Hematological oncology.

Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.

S. Singhal, J. Mehta, D. Tait, 1996, Bone marrow transplantation.

Delayed engraftment associated with splenomegaly in patients undergoing bone marrow transplantation for chronic myeloid leukaemia.

R. Powles, P. Parikh, C. Smith, 1990, Bone marrow transplantation.

Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria

S. Singhal, J. Mehta, B. Sirohi, 2001, Bone Marrow Transplantation.

Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy.

S. Singhal, J. Mehta, T. Hickish, 1996, Leukemia & lymphoma.

Extramedullary disease initially without bone marrow involvement in acute promyelocytic leukaemia.

R. Powles, A. Nandi, A. Zuiable, 1989, Clinical and laboratory haematology.

Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia.

J. Mehta, D. Catovsky, C. Tiley, 1993, Bone marrow transplantation.

Sensitivity of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation to immunotherapy with interferon-α2b

S. Singhal, J. Mehta, R. Powles, 1997, Bone Marrow Transplantation.

Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia.

S. Singhal, J. Mehta, P. Glynne, 1996, Seminars in hematology.

Deletions and rearrangement of CDKN2 in lymphoid malignancy.

M. Yuille, D. Jadayel, E. Nacheva, 1995, Blood.

Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction.

M. Dyer, D. Catovsky, D. Jadayel, 1997, Blood.

Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.

S. Singhal, J. Mehta, D. Tait, 1996, Bone marrow transplantation.

Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.

J. Treleaven, D. Rogers, J. Pritchard, 1989, Journal of clinical pathology.

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.

T. Powles, M. Dowsett, J. Davey, 1989, British Journal of Cancer.